Back to Search
SEEMA IYER, M.D.
M.D.
Geriatric Medicine (Internal Medicine) Physician
NPI: 1437455441IndividualAccepts Medicare
Specialties, Licenses & Credentials
Geriatric Medicine (Internal Medicine) PhysicianPrimary
Internal Medicine — Geriatric Medicine
Code: 207RG0300X
2011002808(MO)
Education
OTHER
Class of 2004
Research & Publications (20)
Oxidation of plasma cysteine/cystine redox state in endotoxin-induced lung injury.
PMID 18664641·Am J Respir Cell Mol Biol·2009
7-preclinical
Measurement of human immunodeficiency virus type 1 preintegration transcription by using Rev-dependent Rev-CEM cells reveals a sizable transcribing DNA population comparable to that from proviral templates.
PMID 19553325·J Virol·2009
8-other
Neurospora crassa fmf-1 encodes the homologue of the Schizosaccharomyces pombe Ste11p regulator of sexual development.
PMID 19417542·J Genet·2009
8-other
Cysteine redox potential determines pro-inflammatory IL-1beta levels.
PMID 19325908·PLoS One·2009
7-preclinical
Oxidation of extracellular cysteine/cystine redox state in bleomycin-induced lung fibrosis.
PMID 18931052·Am J Physiol Lung Cell Mol Physiol·2009
7-preclinical
Recombinant mitochondrial transcription factor A with N-terminal mitochondrial transduction domain increases respiration and mitochondrial gene expression.
PMID 19460293·Mitochondrion·2009
8-other
Peritoneal and pleural sarcoidosis: an unusual association - review and clinical report.
PMID 18664980·Curr Opin Pulm Med·2008
5-case
Signs and symptoms in the pre-psychotic phase: description and implications for diagnostic trajectories.
PMID 18366823·Psychol Med·2008
8-other
Long-term results of living donor liver transplantation for glycogen storage disorders in children.
PMID 17539004·Liver Transpl·2007
8-other
A 'biorelevant' approach to accelerated in vitro drug release testing of a biodegradable, naltrexone implant.
PMID 17482777·Int J Pharm·2007
4-observational
A 'biorelevant' system to investigate in vitro drug released from a naltrexone implant.
PMID 17482393·Int J Pharm·2007
4-observational
Characterization of a potential medium for 'biorelevant' in vitro release testing of a naltrexone implant, employing a validated stability-indicating HPLC method.
PMID 17045445·J Pharm Biomed Anal·2007
8-other
Profiling in vitro drug release from subcutaneous implants: a review of current status and potential implications on drug product development.
PMID 16416503·Biopharm Drug Dispos·2006
6-review
A molecular model to explain paclitaxel and docetaxel sensitivity changes through adduct formation with primary amines in electrospray ionization mass spectrometry.
PMID 15838931·Rapid Commun Mass Spectrom·2005
8-other
Surgical treatment outcomes of localized squamous carcinoma of buccal mucosa.
PMID 15390193·Head Neck·2004
8-other
Evaluation of deuterium isotope effects in normal-phase LC-MS-MS separations using a molecular modeling approach.
PMID 15355579·J Chromatogr Sci·2004
8-other
Roles of the tetratricopeptide repeat domain in O-GlcNAc transferase targeting and protein substrate specificity.
PMID 12724313·J Biol Chem·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 621 S NEW BALLAS RD STE 6017B
SAINT LOUIS, MO 63141 - Phone
- (636) 327-1520
Quick Facts
- NPI
- 1437455441
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 22
- Publications
- 20
Are you this provider?
Claim Your Profile